Physician profile
Rakesh Gupta
NPI 1255329876
$11,976.49
in general payments reported to CMS, 2019-2025
10 companies · $68.30 in 2025
The $68.30 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $102 · 2021: $240 · 2022: $267 · 2023: $190 · 2024: $11K · 2025: $68.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $11K · Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $10,782.53 |
| Food and Beverage | $424.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $10,782.53 | 2024 | Evis Exera III Colonovideoscope, Gastrointestinal Videoscope |
| Abbott Laboratories | $440.80 | 2020-2025 | Freestyle Libre 3, Aveir |
| Janssen Pharmaceuticals, INC | $319.01 | 2022-2023 | Xarelto |
| Esperion Therapeutics, INC. | $142.68 | 2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $121.04 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $70.20 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $35.29 | 2019-2020 | |
| Pfizer INC. | $24.11 | 2021 | |
| Braintree Laboratories, INC. | $21.52 | 2021 | |
| Redhill Biopharma INC. | $19.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.